Phio Pharmaceuticals Corp. Quarterly Debt-to-equity in % from Q3 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Phio Pharmaceuticals Corp. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q4 2023.
  • Phio Pharmaceuticals Corp. Debt-to-equity for the quarter ending December 31, 2023 was 27.2 %, a 64% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 27.2 +10.6 +64% Dec 31, 2023
Q3 2023 25.8 +9.98 +63.2% Sep 30, 2023
Q2 2023 21.7 +7.61 +54% Jun 30, 2023
Q1 2023 20.1 +8.08 +67.3% Mar 31, 2023
Q4 2022 16.6 +6.16 +59.1% Dec 31, 2022
Q3 2022 15.8 +4.94 +45.5% Sep 30, 2022
Q2 2022 14.1 +1.95 +16.1% Jun 30, 2022
Q1 2022 12 -1.45 -10.8% Mar 31, 2022
Q4 2021 10.4 -7.28 -41.1% Dec 31, 2021
Q3 2021 10.9 -8.54 -44% Sep 30, 2021
Q2 2021 12.2 -10.1 -45.3% Jun 30, 2021
Q1 2021 13.5 -13.6 -50.3% Mar 31, 2021
Q4 2020 17.7 -8.73 -33% Dec 31, 2020
Q3 2020 19.4 -0.9 -4.44% Sep 30, 2020
Q2 2020 22.2 Jun 30, 2020
Q1 2020 27.1 Mar 31, 2020
Q4 2019 26.4 Dec 31, 2019
Q3 2019 20.3 Sep 30, 2019
Q4 2013 25.7 +77.4 Dec 31, 2013
Q3 2013 40.6 +127 Sep 30, 2013
Q2 2013 140 Jun 30, 2013
Q1 2013 -135 Mar 31, 2013
Q4 2012 -51.8 Dec 31, 2012
Q3 2012 -86.8 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.